<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-2OZ95Z7S</identifier><date>2009</date><creator>Rožman, Samo</creator><creator>Sonc, Monika</creator><creator>Virant, Igor</creator><relation>documents/doc/2/URN_NBN_SI_doc-2OZ95Z7S_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-2OZ95Z7S_001.txt</relation><format format_type="issue">1</format><format format_type="volume">13</format><format format_type="type">article</format><format format_type="extent">str. 72</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">837499</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-2OZ95Z7S</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Antineoplastic agents</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="eng">Neoplasms</subject><subject language_type_id="eng">Pharmacy service, hospital</subject><title>Hamburg, 22.-24. 1. 2009</title><title>Kongres Evropske zveze onkoloških farmacevtov</title></Record>